Walleye Capital
CALA

Walleye Capital’s Calithera Biosciences, Inc CALA Stock Holding History

Walleye Capital’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,737
Closed -$119 – 2470
2021
Q3 		$119 Sell
2,737
-7,019
-72% -$303K ﹤0.01% 1299
2021
Q2 		$408 Buy
9,756
+8,031
+466% +$353K 0.01% 837
2021
Q1 		$83 Buy
+1,725
New +$100K ﹤0.01% 1042
2019
Q3 		– Sell
-1,870
Closed -$146K – 2382
2019
Q2 		$146K Buy
+1,870
New +$212K 0.02% 1093

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Walleye Capital's CALA Position: Q4 2021 in Review

Walleye Capital sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 2,737 shares — an estimated $119 sold.

Walleye Capital first reported a position in CALA in Q2 2019 and held it in 4 quarters. The position peaked at $146K in Q2 2019. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • Walleye Capital reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • Walleye Capital sold 2,737 Calithera Biosciences, Inc shares in Q4 2021, an estimated $119.
  • Walleye Capital first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 4 quarters.
  • Walleye Capital's Calithera Biosciences, Inc position peaked at $146K in Q2 2019.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Walleye Capital's 13F filing for Q4 2021, filed 3 Mar 2022.